LeMaitre Vascular
LMAT
73.61
-1.25
-1.67%
LeMaitre Vascular
US · LMAT
#2839 by market cap
Listed 1970
73.61
-1.25
-1.67%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Cuts Target Price to $110Market Newswire · 2026/11/5
-
Rating change
Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Maintains Target Price $95Market Newswire · 2026/10/1
-
Rating change
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $94 to $118Market Newswire · 2026/2/26
-
Rating change
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $95 to $120Market Newswire · 2025/11/8
-
Rating change
Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/8/5
-
Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Cuts Target Price to $105Market Newswire · 2026/11/5
-
Rating change
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124Market Newswire · 2026/2/27
-
Rating change
Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Announces Target Price $95Market Newswire · 2026/8/6
-
Rating change
Barrington Downgrades LeMaitre Vascular(LMAT.US) to Hold RatingMarket Newswire · 2026/8/5
-
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $91 to $110Market Newswire · 2026/11/6
-
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $95Market Newswire · 2026/10/13
-
Rating change
Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $127Market Newswire · 2026/5/6
-
Rating change
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/5/6
-
KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold RatingMarket Newswire · 2026/11/5
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT)TipRanks · 2025/11/7
-
Rating change
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $120 to $135Market Newswire · 2026/5/7
-
Rating change
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Lemaitre Vascular (LMAT) and Gilead Sciences (GILD)TipRanks · 2026/6/3
-
Rating change
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/6/3
-
Rating change
Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Cuts Target Price to $93Market Newswire · 2025/11/26
-
Rating change
Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $93Market Newswire · 2025/12/12
-
Rating change
Roth MKM Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $108Market Newswire · 2025/11/7
-
Rating change
Roth MKM Initiates LeMaitre Vascular(LMAT.US) With Buy Rating, Announces Target Price $108Market Newswire · 2025/11/5
-
Rating change
KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold RatingMarket Newswire · 2026/8/5
-
Rating change
Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $97Market Newswire · 2025/8/27
-
Rating change
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $95Market Newswire · 2026/2/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
LeMaitre Vascular discussion 0 comments